Antibody / Antigen interactions
Pharma Diagnostics’ vision is to transform biomolecular interaction analysis – we are the first company to enable SPR label-free analysis on standard equipment that you already have in your laboratory!
Our SoPRano™ platform enables high throughput, plate-based, homogenous SPR assays using a standard absorbance plate reader, enabling the broader adoption of SPR label-free biomolecular analysis at all stages of basic research and discovery.
We provide services to academic institutions and companies involved in basic protein and antibody research, and the discovery of both small molecule and protein therapeutics.
The SoPRano™ platform is highly flexible, with diverse applications in basic research and therapeutic R&D, including:
- Antibody screening
- Protein-protein interactions analysis
- Protein-protein small molecule inhibition assays.
Use SoPRano™ technology to run label-free antibody-antigen interaction screens in high throughput formats without the need for specialist equipment.
The SoPRano™ platform is broadly enabling and has been adapted for a variety of applications in basic research and pharmaceutical discovery and QC.
For information on SoPRano GNR characteristics, QC and stability please click here
Detection of the interaction of anti-human Serum Albumin (hSA) monoclonal antibody (mAb) (Abcam, #ab18081) on hSA conjugated to GNRs (hSA-GNR).
The signal for the interaction of anti-hSA mAb with hSA-GNR is specific, as illustrated by the the lack of cross-reactivity of anti-bSA mAb with hSA-GNR.